285 related articles for article (PubMed ID: 23112078)
1. p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.
Tivey HS; Brook AJ; Rokicki MJ; Kipling D; Davis T
Biogerontology; 2013 Feb; 14(1):47-62. PubMed ID: 23112078
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of stress signalling via p38 MAP kinase in the premature senescence of ataxia telangiectasia and Werner syndrome fibroblasts.
Davis T; Kipling D
Biogerontology; 2009 Jun; 10(3):253-66. PubMed ID: 18830681
[TBL] [Abstract][Full Text] [Related]
3. Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor.
Davis T; Baird DM; Haughton MF; Jones CJ; Kipling D
J Gerontol A Biol Sci Med Sci; 2005 Nov; 60(11):1386-93. PubMed ID: 16339323
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts.
Tivey HS; Rokicki MJ; Barnacle JR; Rogers MJ; Bagley MC; Kipling D; Davis T
J Gerontol A Biol Sci Med Sci; 2013 Sep; 68(9):1001-9. PubMed ID: 23401567
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts.
Davis T; Bachler MA; Wyllie FS; Bagley MC; Kipling D
Ann N Y Acad Sci; 2010 Jun; 1197():45-8. PubMed ID: 20536832
[TBL] [Abstract][Full Text] [Related]
6. Prevention of accelerated cell aging in the Werner syndrome.
Davis T; Haughton MF; Jones CJ; Kipling D
Ann N Y Acad Sci; 2006 May; 1067():243-7. PubMed ID: 16803993
[TBL] [Abstract][Full Text] [Related]
7. Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence.
Davis T; Tivey HS; Brook AJ; Kipling D
Biogerontology; 2015 Feb; 16(1):43-51. PubMed ID: 25214013
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome.
Davis T; Tivey HS; Brook AJ; Grimstead JW; Rokicki MJ; Kipling D
Age (Dordr); 2013 Oct; 35(5):1767-83. PubMed ID: 23001818
[TBL] [Abstract][Full Text] [Related]
9. Absence of premature senescence in Werner's syndrome keratinocytes.
Ibrahim B; Sheerin AN; Jennert-Burston K; Bird JL; Massala MV; Illsley M; James SE; Faragher RG
Exp Gerontol; 2016 Oct; 83():139-47. PubMed ID: 27492502
[TBL] [Abstract][Full Text] [Related]
10. Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts.
Naka K; Tachibana A; Ikeda K; Motoyama N
J Biol Chem; 2004 Jan; 279(3):2030-7. PubMed ID: 14570874
[TBL] [Abstract][Full Text] [Related]
11. The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.
Bagley MC; Dwyer JE; Baashen M; Dix MC; Murziani PG; Rokicki MJ; Kipling D; Davis T
Org Biomol Chem; 2016 Jan; 14(3):947-56. PubMed ID: 26611938
[TBL] [Abstract][Full Text] [Related]
12. Senescence, regulators of alternative splicing and effects of trametinib treatment in progeroid syndromes.
Bramwell LR; Harries LW
Geroscience; 2024 Apr; 46(2):1861-1879. PubMed ID: 37751047
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts.
Davis T; Brook AJ; Rokicki MJ; Bagley MC; Kipling D
Pharmaceuticals (Basel); 2016 Apr; 9(2):. PubMed ID: 27136566
[TBL] [Abstract][Full Text] [Related]
14. The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging.
Davis T; Wyllie FS; Rokicki MJ; Bagley MC; Kipling D
Ann N Y Acad Sci; 2007 Apr; 1100():455-69. PubMed ID: 17460211
[TBL] [Abstract][Full Text] [Related]
15. Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome?
Davis T; Kipling D
Rejuvenation Res; 2006; 9(3):402-7. PubMed ID: 16859481
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and antioxidant response in fibroblasts from Werner and atypical Werner syndromes.
Seco-Cervera M; Spis M; García-Giménez JL; Ibañez-Cabellos JS; Velázquez-Ledesma A; Esmorís I; Bañuls S; Pérez-Machado G; Pallardó FV
Aging (Albany NY); 2014 Mar; 6(3):231-45. PubMed ID: 24799429
[TBL] [Abstract][Full Text] [Related]
17. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes.
Minamino T; Komuro I
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):637-48. PubMed ID: 18762784
[TBL] [Abstract][Full Text] [Related]
18. The Effect of a p38 Mitogen-Activated Protein Kinase Inhibitor on Cellular Senescence of Cultivated Human Corneal Endothelial Cells.
Hongo A; Okumura N; Nakahara M; Kay EP; Koizumi N
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3325-3334. PubMed ID: 28672399
[TBL] [Abstract][Full Text] [Related]
19. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
[TBL] [Abstract][Full Text] [Related]
20. Telomerase expression prevents replicative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains.
Choi D; Whittier PS; Oshima J; Funk WD
FASEB J; 2001 Apr; 15(6):1014-20. PubMed ID: 11292662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
